Goodwin Procter advised SWORD Health on the deal. SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating...
SWORD Health’s $85 Million Series C Funding Round
Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II
Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal. Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a...